ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin motifs) constitute a family of endopeptidases related to matrix metalloproteinases. These proteases have been largely implicated in tissue remodeling and angiogenesis associated with physiological and pathological processes. To elucidate the in vivo functions of ADAMTS-12, we have generated a knockout mouse strain (Adamts12
Introduction
Cancer progression depends not only on the acquisition of new properties by neoplastic cells, but also on a complex cross talk occurring between tumor cells and their microenvironment implicating different types of cells, soluble mediators and cell membrane-associated molecules (Nyberg et al., 2008) . The contribution of proteolytic enzymes to cancer progression has long been associated with their ability to degrade extracellular matrix components and has been recently extended to their capacity to control the activity and bioavailability of these mediators (Egeblad and Werb, 2002; Cauwe et al., 2007; Overall and Blobel, 2007) . Recently, the generation of animal models involving gain or loss of function of matrix metalloproteinases (MMPs) has led to the surprising discovery of tumor-suppressive function for some proteases (Lopez-Otin and Matrisian, 2007) . These host-protective proteases are not produced by tumor cells, but mainly by tumor infiltrating cells including inflammatory cells (MMP-8) (Balbin et al., 2003) and fibroblastic cells (Jost et al., 2006) . These recent findings have broken the dogma of proteases as simple positive regulators of cancer progression and emphasize the urgent need in identifying individual proteases as host-protective partners or tumor-promoting agents.
Among proteases with putative tumor-suppressive functions are the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs), MMP-related enzymes characterized by the presence of at least one thrombospondin type I domain (TSP-1) (Cal et al., 2001; Porter et al., 2004 Porter et al., , 2005 Bai et al., 2009) . Their multi-domain structure endows these secreted proteins with various functions including the control of cell proliferation, apoptosis, adhesion and migration Rocks et al., 2008; Bai et al., 2009) . It is worth noting that ADAMTS-1 and ADAMTS-8 display antiangiogenic properties (Vazquez et al., 1999; Liu et al., 2006) . Our recent studies have highlighted the antitumor properties exhibited by ADAMTS-12 (Cal et al., 2001; Llamazares et al., 2007) . In accordance with this concept of ADAMTS-12 being a host-protective enzyme, ADAMTS12 is epigenetically silenced in human tumor samples and tumor cell lines (Moncada-Pazos et al., 2009) . However, the exact contribution of ADAMTS-12 during the different steps of cancer progression including angiogenesis remains to be elucidated. To address this important issue, we have generated mutant mice lacking the Adamts12 gene. Adamts12 deficiency did not cause obvious abnormalities during embryonic development or in adult mice. Therefore, mutant mice provide a novel and useful tool to investigate Adamts-12 functions in pathological angiogenesis. Through different complementary approaches, we provide evidence that Adamts-12 protects the host against tumor angiogenesis, growth and invasion.
Results
Adamts12-deficient mice are viable without any obvious phenotype The biological functions of ADAMTS-12, a metalloprotease-related enzyme overexpressed in human cancers (Porter et al., 2004) , are poorly understood. To establish a mutant mouse strain deficient for Adamts12 gene (KO, Adamts12 À/À mice), the targeting vector was designed to replace the exons 6 and 7 (corresponding to the N-terminal part of the catalytic domain) by a neomycin-phosphoglycerate kinase (NEO-PGK) cassette ( Figure 1a ) and to introduce a frame shift. Embryonic stem clones generated by homologous recombination ( Figure 1b) were injected into C57Bl/6J blastocysts to generate chimeric males. Heterozygous mice from the F1 generation were intercrossed to generate Adamts12-deficient mice that were obtained in the Mendelian ratio. We checked mice genotypes by PCR (Figure 1c) .
The expression of Adamts12 was determined by reverse transcriptase (RT) PCR in different organs. In WT mice, Adamts12 was expressed in some organs, including the ovary, mammary gland, uterus, lung, ear cartilage and lymph node (Figure 1d ). Adamts12 was not expressed in the heart, kidney, bone, liver, brain, intestine, testis, muscle, skin, eyes and spleen (data not shown). As expected, tissues from Adamts12 À/À mice did not produce any Adamts-12 in all organs tested, as assessed by RT-PCR amplification using primers targeting the catalytic domain ( Figure 1d ) and the prodomain (data not shown). These RT-PCR analysis show that no residual mRNA was produced in mutant mice because of the frame-shift introduced during exon replacement.
Despite Adamts12 deficiency, mutant mice developed normally were fertile and had long-term survival rates indistinguishable from those of their wild-type (WT) counterpart. No obvious phenotype was detected. These findings clearly indicate that Adamts12 is dispensable for embryonic and adult mouse development and growth.
Adamts12 deficiency affects tumoral angiogenesis In the course of the phenotyping of Adamts12 À/À mice, we evaluated its expression in pathological conditions. Adamts12 expression was first investigated during laserinduced choroidal neovascularization by RT-PCR analyses performed at various time points after laser burn (Lambert et al., 2003) . Adamts12 expression was never detected at any stage of choroidal neovascularization (data not shown), excluding the potential implication of Adamts-12 in choroidal angiogenesis.
The overexpression of ADAMTS12 in various human cancers (Cal et al., 2001 ) prompted us to explore its putative functions in tissue remodeling associated with cancer development. We applied three models of angiogenesis, which have been previously successfully used to evaluate the contribution of different metalloproteinases during angiogenic processes (Masson et al., 2002; Berndt et al., 2006 Berndt et al., , 2008 . The transplantation system is a highly sensitive tool to inspect the kinetic of early steps of host stromal response to tumor signals (Mueller and Fusenig, 2004; Jost et al., 2007 Jost et al., , 2008 . Malignant PDVA cells issued from carcinogen treatment of murine keratinocytes (Fusenig et al., 1983) precultured on a type I collagen gel were transplanted onto WT (n ¼ 14) and Adamts12-deficient mice (n ¼ 14). An early endothelial cell migration toward the tumor layer can be visualized through double immunostaining carried out to distinguish tumor cells (keratin positive) and vessels (CD31 positive cells or type IV collagenpositive basement membrane) . Two different patterns of invasion were observed 21 days after transplantation ( Figure 2) . A low vascularized profile scored þ was characterized by blood vessel infiltration of the collagen gel without reaching the tumor layer. Then, once blood vessels have reached tumor cell layers, malignant keratinocytes formed tumor sprouts that invaded downward the remodeled host tissue and were intermingled with new vessels (Figure 2 ). Such highly vascularized pattern was scored þ þ þ . Tumor vascularization and invasion was improved in Adamts12 À/À mice. Indeed, 86% of transplants were highly vascularized (scored þ þ þ ), whereas 14% of samples were scored þ . In WT mice, the percentage of transplants scored þ þ þ fell down to 57% and that of low vascularized transplants reached 43% (P ¼ 0.027, w 2 -test) ( Figure 2a ). To further confirm this distinct invasive profile, an original method of computerized image analysis allowing a concomitant quantification of blood vessel recruitment and tumor cell invasion was applied to all samples. The distribution of tumor cell and endothelial cell densities was determined as a function of distance to the top of the tumor (Figures 2b  and c) . With this aim, a grid formed from the dilatation of tumor boundaries was superposed onto tumor and vascularization images as previously described . The degree of superimposition of curves corresponding to vessel and tumor densities determines tumor vascularization. Yellow spots in Figure 2 delineate areas of tumor in which tumor cells and blood vessels were intermingled, reflecting tumor vascularization. In Adamts12 À/À mice, invasion and migration process took place to a much larger extent (Figures 2b and c ; Po0.05). A stronger invasion characterized by a deeper extension of tumor cells was observed in Adamts12 À/À mice (migration up to L max ¼ 3.55±0.4 mm in KO mice versus L max ¼ 2.5 ± 0.4 mm in WT mice, Po0.05, Mann-Whitney test). In addition, blood vessels migrated roughly toward tumor cells leading to increased overlapping area of tumor cells and blood vessels (Figures 2b and c, yellow spot) . Indeed, the area of vessels intermingled with tumor cells was twice higher in mutant mice (0.27 versus 0.13 mm 2 in WT mice). These data indicate that Adamts12 deficiency in host tissue is associated with an acceleration of the angiogenic response and increased tumor invasion into the host tissue. It is worth noting that malignant keratinocytes used in this model did not express Adamts12 in vitro, whereas human ADAMTS-12 was detected in tumor transplants. The RT-PCR analysis of tumor cell layer and the host compartment separated through laser microdissection revealed that Adamts12 was expressed by host cells rather than by tumor cells (Figure 2d showing that ADAMTS12 as other family members (ADAMTS2, 7, 8 and 10) are predominantly expressed in stromal fibroblasts from human mammary tissues, but not in breast cancer cells (Porter et al., 2004) . Altogether, these observations suggest that fibroblastic cells are an important source of ADAMTS-12 and respond to the presence of tumor cells by producing this enzyme.
Adamts-12 affects in vivo and ex vivo angiogenesis The angiogenic response to basic fibroblast growth factor (bFGF) was then investigated in WT and mutant mice. Matrigel (500 ml) containing heparin (10 U/ml) and bFGF (250 ng/ml) were injected subcutaneously into mice (n ¼ 16). To quantify functional vessel recruitment, hemoglobin concentrations were measured in the plugs harvested 7 days after injection (Berndt et al., 2006) . The angiogenic response induced by bFGF was again higher 
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À/À than in WT mice. In WT mice, the mean hemoglobin content was two-fold reduced (0.65±0.1 Hb (mg/ml) per mg of plug in WT mice versus 1.65 ± 0.5 Hb (mg/ml) per mg of plug in Adamts12 À/À mice), and the percentage of poorly vascularized plugs (hemoglobin concentration lower than 0.5 Hb (mg/ml) per mg of plug) reached 56% (9 of 16) in WT mice, whereas it was o12% (2 of 16) in mutant mice (Po0.05).
To further study the contribution of Adamts-12 in neovessel formation, aortic explants issued from mutant or WT mice were embedded into a threedimensional type I collagen gel in the presence of serum Angiogenesis in Adamts12-deficient mice M El Hour et al corresponding to their genotype (Figure 3a ). An increased angiogenic response was observed in Adamts12 À/À mice as evidenced by increased sprout density (Figure 3b , left graph) and vessel length (Figure 3b, right graph) . As the formation of capillary-like structures is associated with the spreading out of mural cells, we performed immunohistochemical labeling on whole mount of aortic rings. Interestingly, increased mural cell recruitment detected by NG2 labeling was observed in IB4-positive capillaries issued from Adamts12 À/À mice (Figure 3c ). Computerized quantification revealed that the mean area of colocalization between IB4-positive endothelial cells and NG2-positive mural cells was twice higher in sprouts issued from Adamts12 À/À mice as compared with those from WT explants (Figure 3d ). These data reflect an increased maturation of blood vessels in the absence of Adamts-12. Altogether, these findings indicate that ADAMTS12 is a negative regulator of angiogenesis.
The finding that Adamts12 deficiency resulted in an acceleration of the angiogenic response led us to postulate that cells overexpressing ADAMTS-12 would have opposite effect and would inhibit it. To address this question, we next evaluated the impact of medium conditioned by a population of MCF7 cells overexpressing human FLAG-tagged ADAMTS-12 (MCF7p ADAMTS-12 FLAG) on neovessel formation in another experimental model using aortic rings issued from a rat. The presence of ADAMTS-12 in the conditioned media was assessed by western blot (Figure 4d ) using an anti-FLAG antibody allowing the detection of a specific band of molecular mass E175 kDa. In accordance with our hypothesis, the medium of cells overexpressing ADAMTS-12 inhibited the angiogenic response as revealed by a reduction vessel length (Figure 4b ) and vessel maturation through pericyte coverage (Figure 4c) .
We next determined whether the antitumorigenic effect of ADAMTS-12 could be ascribed to its catalytic function. With this aim, new MCF7 transfectants were generated to produce inactive mutants of ADAMTS-12 or intact ADAMTS-12. Point mutations of two key amino acids of the catalytic site (H465Q/E466A) were performed as previously described (Cal et al., 2001) . The mutated ADAMTS-12 form was produced at similar levels than the WT form as assessed by western ) between pericytes and endothelial cells was determined by using a computer-assisted method quantification by implementing an algorithm using MATLAB7.1 software. The assay was conducted by using at least triplicate culture per condition and results are those of a representative assay out of three. *Po0.05 (Mann-Whitney test). , inactive mutant ADAMTS-12 (MCF7pH465Q/E466A) or not expressing ADAMTS-12 (MCF7pCONTROL) were generated by stable transfection, and their conditioned media were tested in the rat aortic ring assay. The double point mutation in the catalytic site did not affect the inhibitory effect of ADAMTS-12 on vessel sprouting (left panel) and on vessel coverage by pericytes (right panel). Similar results were obtained with two clones of each transfectants. The assay was conducted by using at least triplicate culture per condition and results are those of a representative assay out of three. *Po0.05; ***Po0.001 (Mann-Whitney test). (d) Western blot analysis of the ADAMTS-12-expressing MCF7 cells (MCF7p ADAMTS-12-FLAG), control cells (MCF7p CONTROL-FLAG) and the mutated ADAMTS-12 (MCF7p H465Q/E466A-FLAG) in cell extracts and conditioned media concentrated 10-fold using Amicon Ultra (Millipore, Billerica, MA, USA). ADAMTS-12 was visualized by using an antibody raised against the Flag epitope with anti-FLAG-M2 antibodies (Sigma-Aldrich).
Angiogenesis in Adamts12-deficient mice M El Hour et al blotting (Figure 4d ). These mutations in the catalytic domain did not impair the antiangiogenic effect induced by medium conditioned by transfectants (Figures 4d and e) . Indeed, the medium conditioned by cells overexpressing intact ADAMTS-12 or mutated ADAMTS-12 inhibited the spreading out of endothelial cells as assessed by a reduction of vessel length (Figure 4d ) and of vessel maturation through pericyte coverage (Figure 4e ). These results suggest that the catalytic activity of ADAMTS-12 is dispensable for its angioinhibitory function. Our data are in line with our previous report showing that ADAMTS-12 inhibits the formation of vascular endothelial growth factor-induced tubular structures in BAE-1 cells (Llamazares et al., 2007) . The finding of antiangiogenic effects for a member of the ADAMTS family is not unprecedented as it has also been described for ADAMTS-1 and ADAMTS-8 (Vazquez et al., 1999; Dunn et al., 2006) . However, the originality of our findings relies on the identification of a key host ADAMTS-12 contribution in the host protection toward the angiogenic response induced by tumor cells. This report based on the generation of a novel loss-offunction animal model provides the first demonstration of the antiangiogenic properties of a single host ADAMTS. Moreover, in contrast to ADAMTS-1 whose proteolytic activity is apparently required for its antiangiogenesis property , the angioinhibitory property of ADAMTS-12 does not depend on its catalytic activity. We cannot ruled out the possibility that ADAMTS-12 can sequester vascular endothelial growth factor through its C-terminal thrombospondin domain(s) and the spacer region as previously described for ADAMTS-1 . Addressing this issue would require a careful dissection of the complex C-terminal part of ADAMTS-12 containing seven thrombospondin repeats, two spacers and a PLAC domain, which is out of the scope of this study.
In conclusion, we propose that the ADAMTS-12 production induced in response to the presence of cancer cells could have a beneficial protective effect toward tumor growth and invasion. The new generation of Adamts12-deficient mice provides a suitable tool to give new insights into the in vivo functions of this enzyme, which are presently unknown. In addition, this new transgenic tool paves the way for further investigations on the biological functions of ADAMTS-12 in various pathological conditions in which the enzyme is putatively involved such as asthma (Kurz et al., 2006) and arthritis (Bai et al., 2009) .
